[1] Christakos S, Li SS, DeLa Cruz J, et al. Vitamin D and bone. Handb Exp Pharmacol, 2020; 262, 47−63.
[2] Cashman KD. Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int, 2020; 106, 14−29. doi:  10.1007/s00223-019-00559-4
[3] Lu JX, Liu XB, Chen J, et al. The vitamin D nutritional status in Chinese urban women of child-bearing age from 2010 to 2012. Chin J Prev Med, 2017; 51, 112−6. (In Chinese)
[4] Liu XB, Zhang Y, Mao DQ, et al. Serum vitamin D levels of Chinese rural women of childbearing age in 2010-2012. J Hyg Res, 2017; 46, 367−72. (In Chinese)
[5] Hu YC, Wang R, Mao DQ, et al. Vitamin D nutritional status of Chinese pregnant women, comparing the Chinese national nutrition surveillance (CNHS) 2015-2017 with CNHS 2010-2012. Nutrients, 2021; 13, 2237. doi:  10.3390/nu13072237
[6] Cheng XG, Zhao KP, Zha XJ, et al. Opportunistic screening using low-dose CT and the prevalence of osteoporosis in China: a nationwide, multicenter study. J Bone Miner Res, 2021; 36, 427−35.
[7] Wang LH, Yu W, Yin XJ, et al. Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study. JAMA Netw Open, 2021; 4, e2121106. doi:  10.1001/jamanetworkopen.2021.21106
[8] Ma CF, Li X, Li W, et al. Osteomalacia induced by vitamin D deficiency: a case report. Chin J Osteoporos Bone Miner Res, 2020; 13, 357−61. (In Chinese)
[9] Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2011; 96, 1911−30. doi:  10.1210/jc.2011-0385
[10] Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr, 2006; 84, 18−28. doi:  10.1093/ajcn/84.1.18
[11] Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int, 2005; 16, 713−6. doi:  10.1007/s00198-005-1867-7
[12] Grant WB, Al Anouti F, Boucher BJ, et al. A narrative review of the evidence for variations in serum 25-hydroxyvitamin D concentration thresholds for optimal health. Nutrients, 2022; 14, 639. doi:  10.3390/nu14030639
[13] Kramer H, Camacho P, Aloia J, et al. Association between 25-hydroxyvitamin D and intact parathyroid hormone levels across latitude among adults with African ancestry. Endocr Pract, 2016; 22, 911−9. doi:  10.4158/EP151079.OR
[14] Gallagher JC, Jindal PS, Smith LM. Vitamin D does not increase calcium absorption in young women: a randomized clinical trial. J Bone Miner Res, 2014; 29, 1081−7. doi:  10.1002/jbmr.2121
[15] Xu F, Li F, Li L, et al. Vitamin D as a risk factor for the presence of asymptomatic uterine fibroids in premenopausal Han Chinese women. Fertil Steril, 2021; 115, 1288−93. doi:  10.1016/j.fertnstert.2020.12.001
[16] Abbas S, Chang-Claude J, Linseisen J. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer, 2009; 124, 250−5. doi:  10.1002/ijc.23904
[17] Di Medio L, Brandi ML. Advances in bone turnover markers. Adv Clin Chem, 2021; 105, 101−40.
[18] Kuchuk NO, Pluijm SMF, van Schoor NM, et al. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab, 2009; 94, 1244−50. doi:  10.1210/jc.2008-1832
[19] Lee DY, Jee JH, Cho YY, et al. Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis. Osteoporos Int, 2017; 28, 1377−84. doi:  10.1007/s00198-016-3892-0
[20] Sai AJ, Walters RW, Fang X, et al. Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab, 2011; 96, E436−46. doi:  10.1210/jc.2010-1886
[21] Ismail TST, Muda BC, Rosdi RAM, et al. Determining the required vitamin D level for bone health based on bone turnover markers. Korean J Clin Lab Sci, 2017; 49, 337−44. doi:  10.15324/kjcls.2017.49.4.337
[22] Lu HK, Zhang Z, Ke YH, et al. High prevalence of vitamin D insufficiency in China: relationship with the levels of parathyroid hormone and markers of bone turnover. PLoS One, 2012; 7, e47264. doi:  10.1371/journal.pone.0047264
[23] Krasniqi E, Boshnjaku A, Wagner KH, et al. Association between polymorphisms in vitamin D pathway-related genes, vitamin d status, muscle mass and function: a systematic review. Nutrients, 2021; 13, 3109. doi:  10.3390/nu13093109
[24] Ruiz-Ballesteros AI, Meza-Meza MR, Vizmanos-Lamotte B, et al. Association of vitamin D metabolism gene polymorphisms with autoimmunity: evidence in population genetic studies. Int J Mol Sci, 2020; 21, 9626. doi:  10.3390/ijms21249626
[25] Shan XY, Zhao XY, Li SR, et al. Association of vitamin D gene polymorphisms and serum 25-hydroxyvitamin D in Chinese women of childbearing age. J Hyg Res, 2022; 51, 961−8. (In Chinese)
[26] Yu DM, Zhao LY, Zhang J, et al. China nutrition and health surveys (1982−2017). China CDC Wkly, 2021; 3, 193−5. doi:  10.46234/ccdcw2021.058
[27] Tomal JH, Ciborowski JJH. Ecological models for estimating breakpoints and prediction intervals. Ecol Evol, 2020; 10, 13500−17. doi:  10.1002/ece3.6955
[28] Otani K, Kanno K, Akutsu T, et al. Applying machine learning to determine 25(OH)D threshold levels using data from the AMATERASU vitamin D supplementation trial in patients with digestive tract cancer. Nutrients, 2022; 14, 1689. doi:  10.3390/nu14091689
[29] Durazo-Arvizu RA, Dawson-Hughes B, Sempos CT, et al. Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. J Nutr, 2010; 140, 595−9. doi:  10.3945/jn.109.116681
[30] National Health Commission of the People’s Republic of China. WS/T 677-2020 Method for vitamin D deficiency screening. Beijing: Standards Press of China, 2020. (In Chinese)
[31] Hu YC, Li SR, Wang J, et al. Threshold for relationship between vitamin D and parathyroid hormone in Chinese women of childbearing age. Int J Environ Res Public Health, 2021; 18, 13060. doi:  10.3390/ijerph182413060
[32] Steingrimsdottir L, Gunnarsson O, Indridason OS, et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA, 2005; 294, 2336−41. doi:  10.1001/jama.294.18.2336
[33] Adami S, Viapiana O, Gatti D, et al. Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. Bone, 2008; 42, 267−70. doi:  10.1016/j.bone.2007.10.003
[34] Niculescu DA, Deacu LG, Caragheorgheopol A, et al. Combined effects of vitamin D status, renal function and age on serum parathyroid hormone levels. Front Endocrinol (Lausanne), 2021; 12, 657991. doi:  10.3389/fendo.2021.657991
[35] Lombardi G, Ziemann E, Banfi G, et al. Physical activity-dependent regulation of parathyroid hormone and calcium-phosphorous metabolism. Int J Mol Sci, 2020; 21, 5388. doi:  10.3390/ijms21155388
[36] Jorde R, Grimnes G. Serum PTH is not a good marker for defining a threshold for vitamin D deficiency. Endocr Connect, 2020; 9, 396−404. doi:  10.1530/EC-20-0067
[37] Tan KML, Saw S, Sethi SK. Vitamin D and its relationship with markers of bone metabolism in healthy Asian women. J Clin Lab Anal, 2013; 27, 301−4. doi:  10.1002/jcla.21602
[38] Shan XY, Zhao XY, Li SR, et al. Association of serum 25(OH)D with metabolic syndrome in Chinese women of childbearing age. Nutrients, 2022; 14, 2301. doi:  10.3390/nu14112301
[39] Li M, Lv F, Zhang Z, et al. Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density. Osteoporos Int, 2016; 27, 1907−16. doi:  10.1007/s00198-015-3475-5
[40] Pasco JA, Henry MJ, Kotowicz MA, et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res, 2004; 19, 752−8. doi:  10.1359/jbmr.040125
[41] Sharan K, Siddiqui JA, Swarnkar G, et al. Role of calcium-sensing receptor in bone biology. Indian J Med Res, 2008; 127, 274−86.
[42] Al-Daghri NM, Yakout S, Al-Shehri E, et al. Inflammatory and bone turnover markers in relation to PTH and vitamin D status among Saudi postmenopausal women with and without osteoporosis. Int J Clin Exp Med, 2014; 7, 2812−9.
[43] Jorde R, Stunes AK, Kubiak J, et al. Effects of vitamin D supplementation on bone turnover markers and other bone-related substances in subjects with vitamin D deficiency. Bone, 2019; 124, 7−13. doi:  10.1016/j.bone.2019.04.002
[44] Wu F, Wills K, Laslett LL, et al. Cut-points for associations between vitamin D status and multiple musculoskeletal outcomes in middle-aged women. Osteoporos Int, 2017; 28, 505−15. doi:  10.1007/s00198-016-3754-9
[45] Ramasamy I. Vitamin D metabolism and guidelines for vitamin D supplementation. Clin Biochem Rev, 2020; 41, 103−26. doi:  10.33176/AACB-20-00006
[46] Liu WH, Hu J, Fang YY, et al. Vitamin D status in Mainland of China: A systematic review and meta-analysis. eClinicalMedicine, 2021; 38, 101017. doi:  10.1016/j.eclinm.2021.101017
[47] van Schoor N, Lips P. Global overview of vitamin D status. Endocrinol Metab Clin North Am, 2017; 46, 845−70. doi:  10.1016/j.ecl.2017.07.002
[48] Jiang X, Kiel DP, Kraft P. The genetics of vitamin D. Bone, 2019; 126, 59−77. doi:  10.1016/j.bone.2018.10.006
[49] Li LH, Yin XY, Wu XH, et al. Serum 25(OH)D and vitamin D status in relation to VDR, GC and CYP2R1 variants in Chinese. Endocr J, 2014; 61, 133−41. doi:  10.1507/endocrj.EJ13-0369